AI-based technology could help accelerate clinical trials for glaucoma
The technology, supported by an artificial intelligence (AI) algorithm, could help accelerate clinical trials, and eventually may be used in detection and diagnostics, according to the Wellcome-funded study published today in Expert Review of Molecular Diagnostics.
No hay comentarios:
Publicar un comentario